Seguir
Gareth Wilson
Gareth Wilson
Francis Crick Institute, UCL Cancer Institute
Dirección de correo verificada de crick.ac.uk - Página principal
Título
Citado por
Citado por
Año
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
N McGranahan, AJS Furness, R Rosenthal, S Ramskov, R Lyngaa, ...
Science 351 (6280), 1463-1469, 2016
29282016
Tracking the evolution of non–small-cell lung cancer
M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ...
New England Journal of Medicine 376 (22), 2109-2121, 2017
21442017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ...
Nature 545 (7655), 446-451, 2017
16712017
The minimum information about a genome sequence (MIGS) specification
D Field, G Garrity, T Gray, N Morrison, J Selengut, P Sterk, T Tatusova, ...
Nature biotechnology 26 (5), 541-547, 2008
13412008
Allele-specific HLA loss and immune escape in lung cancer evolution
N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ...
Cell 171 (6), 1259-1271. e11, 2017
11392017
Neoantigen-directed immune escape in lung cancer evolution
R Rosenthal, EL Cadieux, R Salgado, MA Bakir, DA Moore, CT Hiley, ...
Nature 567 (7749), 479-485, 2019
7142019
Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal
S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ...
Cell 173 (3), 595-610. e11, 2018
5402018
The Mars Pathfinder atmospheric structure investigation/meteorology (ASI/MET) experiment
JT Schofield, JR Barnes, D Crisp, RM Haberle, S Larsen, JA Magalhaes, ...
Science 278 (5344), 1752-1758, 1997
5361997
Fc effector function contributes to the activity of human anti-CTLA-4 antibodies
FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ...
Cancer cell 33 (4), 649-663. e4, 2018
5312018
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
CM Blakely, TBK Watkins, W Wu, B Gini, JJ Chabon, CE McCoach, ...
Nature genetics 49 (12), 1693-1704, 2017
4782017
Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors
FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ...
Immunity 46 (4), 577-586, 2017
4092017
Methylome analysis using MeDIP-seq with low DNA concentrations
O Taiwo, GA Wilson, T Morris, S Seisenberger, W Reik, D Pearce, S Beck, ...
Nature protocols 7 (4), 617-636, 2012
3352012
Integrated Genetic and Epigenetic Analysis Identifies Haplotype-Specific Methylation in the FTO Type 2 Diabetes and Obesity Susceptibility Locus
CG Bell, S Finer, CM Lindgren, GA Wilson, VK Rakyan, AE Teschendorff, ...
PloS one 5 (11), e14040, 2010
3352010
Typing and subtyping of influenza viruses in clinical samples by PCR
KE Wright, GA Wilson, D Novosad, C Dimock, D Tan, JM Weber
Journal of Clinical Microbiology 33 (5), 1180-1184, 1995
2651995
Pervasive chromosomal instability and karyotype order in tumour evolution
TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ...
Nature 587 (7832), 126-132, 2020
2602020
Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy
N Murugaesu, GA Wilson, NJ Birkbak, TBK Watkins, N McGranahan, ...
Cancer discovery 5 (8), 821-831, 2015
2562015
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
M Jamal-Hanjani, GA Wilson, S Horswell, R Mitter, O Sakarya, ...
Annals of Oncology 27 (5), 862-867, 2016
2452016
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
N Kanu, E Grönroos, P Martinez, RA Burrell, X Yi Goh, J Bartkova, ...
Oncogene 34 (46), 5699-5708, 2015
1832015
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution
S López, EL Lim, S Horswell, K Haase, A Huebner, M Dietzen, ...
Nature genetics 52 (3), 283-293, 2020
1822020
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
P Guilhamon, M Eskandarpour, D Halai, GA Wilson, A Feber, ...
Nature communications 4 (1), 2166, 2013
1802013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20